Send feedback

SPEF2 p.Ala934Pro

c.2800G>C · rs13170390 · VCV403479

Benign Multiple submitters
Classification
Benign
ClinVar
Review
Multiple submitters ★★☆☆
ClinVar · 4 submitters
AlphaMissense
likely benign
0.0582 · ACMG-weighted
gnomAD v4.1
Common
common (popmax 82.4%, mid) — too common for a highly-penetrant pathogenic allele
Missense predictors
0/3 damaging
AlphaMissense, REVEL, SaProt
Conditions
1
spermatogenic failure 43

Computational evidence

Protein change
AlphaMissense0.0582likely benign
REVEL0.02moderately benign-leaning
SaProtLLR -5.24tolerated
⇒ AlphaMissense, REVEL and SaProt all call this tolerated.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP -5.4GERP -3.1
Regional constrainto/e 1.02unconstrained · MANE · 197 kb · p 0.46 · regional, not allelic
Overall
CADD0.03PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 82.4% Middle Eastern · 4,992/6,058 alleles
Filtering AF 80.5% ClinGen BA1/BS1 input FAF95, joint · FAF99 79.7%
Overall 77.6% 1,251,449/1,613,346 alleles · common exomes 1,137,128/1,461,264 · genomes 114,321/152,082 · joint denominator
Ancestry group Frequency 1 in
Amishnot grpmax-eligible 82.8% 1
Middle Easterngrpmax 82.4% 1
Ashkenazi Jewishnot grpmax-eligible 80% 1
East Asian 79.7% 1
European (non-Finnish) 79.1% 1
Remaining individualsnot grpmax-eligible 77.5% 1
Finnishnot grpmax-eligible 77.1% 1
Admixed American 71.2% 1
South Asian 69.9% 1
African / African-American 66.4% 2

Amish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
SPEF2
Protein
p.Ala934Pro
Coding
c.2800G>C
MANE Select
NM_024867
dbSNP
rs13170390
Type
single nucleotide variant
Location
chr5:35709082 (GRCh38)
Gene constraint
LOEUF 0.923 · pLI <0.01 (gnomAD)
Structure
AlphaFold pLDDT 71.30
Residue 934
the 'disordered' region; a UniProt-annotated variant site (in spgf43; loss of protein expression; changed sperm axoneme assembly); a UniProt-annotated variant site (found in a female patient with primary ciliary dyskinesia-like symptoms including chronic sinusitis, bronchitis, chronic wet cough and recurrent pneumonia; uncertain significance); a UniProt-annotated variant site (in)
Full SPEF2 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/spef2-p-ala934pro (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown